Bylsma L, Nielson C, Fryzek J, Saad H, Crawford J. Edit chemotherapy relative dose intensity, overall survival, and hematologic toxicity in solid-tumor cancer patients: A literature review and meta-analysis. Poster presentation [preview] at 37th ICPE (International Conference on Pharmacoepidemiology & Therapeutic Rick Management), virtual conference, August 2021.
A common outcome of cancer chemotherapy is lowering the relative dose intensity (RDI). Some studies have indicated that RDI may be a factor in overall survival. The systematic literature review and meta-analysis reported herein assessed the potential association between RDI and patient survival.